Cargando…

Development of a vaccine to prevent Japanese encephalitis: a brief review

Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper...

Descripción completa

Detalles Bibliográficos
Autor principal: Wiwanitkit, Viroj
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840557/
https://www.ncbi.nlm.nih.gov/pubmed/20360904
_version_ 1782178993769807872
author Wiwanitkit, Viroj
author_facet Wiwanitkit, Viroj
author_sort Wiwanitkit, Viroj
collection PubMed
description Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed.
format Text
id pubmed-2840557
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-28405572010-04-01 Development of a vaccine to prevent Japanese encephalitis: a brief review Wiwanitkit, Viroj Int J Gen Med Review Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed. Dove Medical Press 2009-12-29 /pmc/articles/PMC2840557/ /pubmed/20360904 Text en © 2009 Wiwanitkit, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Wiwanitkit, Viroj
Development of a vaccine to prevent Japanese encephalitis: a brief review
title Development of a vaccine to prevent Japanese encephalitis: a brief review
title_full Development of a vaccine to prevent Japanese encephalitis: a brief review
title_fullStr Development of a vaccine to prevent Japanese encephalitis: a brief review
title_full_unstemmed Development of a vaccine to prevent Japanese encephalitis: a brief review
title_short Development of a vaccine to prevent Japanese encephalitis: a brief review
title_sort development of a vaccine to prevent japanese encephalitis: a brief review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840557/
https://www.ncbi.nlm.nih.gov/pubmed/20360904
work_keys_str_mv AT wiwanitkitviroj developmentofavaccinetopreventjapaneseencephalitisabriefreview